Emclaire Financial Corp Reports 35.7% Increase in Quarterly

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
120
Emclaire Financial Corp Reports 35.7% Increase in Quarterly Earnings

EMLENTON, Pa., July 20, 2018 (GLOBE NEWSWIRE) -- Emclaire Financial Corp (NASDAQ: EMCF ), the parent holding company of The Farmers National Bank of Emlenton, reported consolidated net income of $1.4 million, or $0.62 per common share, for the three months ended June 30, 2018, an increase of $372,000, or 35.7%, from net income of $1.0 million, or $0.48 per common share, reported for the same period in 2017.  Net income for the six-month period ended June 30, 2018 was $2.8 million, or $1.21 per diluted share, an increase of $778,000, or 38.9%, from net income of $2.0 million, or $0.92 per diluted share, for the same period in 2017.

The increase in net income for both periods compared to the same period in 2017 resulted from increases in net interest income and noninterest income, partially offset by increases in noninterest expense and the provision for loan losses.  The Corporation realized an annualized return on average assets of 0.74% and an annualized return on average equity of 9.58% for the quarter ended June 30, 2018, compared to 0.58% and 7.50%, respectively, for the same period in 2017.

William C. Marsh, Chairman, President and Chief Executive Officer of the Corporation and the Bank, noted, “The Board of Directors, management and I are pleased with the results for the first half of 2018.  We achieved strong earnings and balance sheet growth while managing expenses and maintaining strong asset quality.  We have recently announced plans to acquire Community First Bancorp, Inc., which will strengthen our market position in Clarion and Jefferson counties and build a stronger franchise in the Pittsburgh and Western Pennsylvania region.  We remain focused on sustaining a sound capital base while providing an attractive return to our shareholders and are well-positioned for future profitable growth.”

OPERATING RESULTS OVERVIEW

Net income increased $372,000, or 35.7%, to $1.4 million, or $0.62 per common share, for the three months ended June 30, 2018, compared to $1.0 million, or $0.48 per common share, for the same period in 2017. The increase resulted from increases in net interest income and noninterest income of $826,000 and $181,000, respectively, and a decrease in provision for income taxes of $32,000, partially offset by increases in noninterest expense and the provision for loan losses of $568,000 and $99,000, respectively.

Net interest income increased $826,000, or 15.4%, to $6.2 million for the three months ended June 30, 2018 from $5.4 million for the same period in 2017.  The increase in net interest income resulted from an increase in interest income of $1.0 million, or 15.6%, as the Corporation experienced a $45.5 million increase in the average balance of loans.  Partially offsetting the increase in interest income, interest expense increased $176,000, or 16.5%, as the Corporation's average balance of interest-bearing deposits increased $68.6 million, partially offset by a $20.9 million decrease in the average balance of borrowed funds. The increases in the Corporation's loans and interest-bearing deposit balances resulted from strong production across the Bank's franchise and the third quarter 2017 acquisition of Northern Hancock Bank and Trust Co. (NHBT), which added approximately $18.5 million in loans and $19.7 million in deposits to the Bank.

Noninterest income increased $181,000, or 20.9%, to $1.0 million for the three months ended June 30, 2018 from $868,000 for the same period in 2017.  During the quarter ended June 30, 2017, the Corporation recorded a $508,000 other-than-temporary impairment charge on a subordinated debt investment issued by First NBC Bank Holding Company.  Partially offsetting the impairment charge, the Corporation realized security gains of $350,000 during the quarter ended June 30, 2017. Fees and service charges increased $28,000 as overdraft charges for the three months ended June 30, 2018 outpaced the same period in the prior year and other income increased $117,000 due to increased interchange fee income and fair value adjustments related to the Corporation's equity securities. Partially offsetting these favorable items, gains on the sales of loans totaled $2,000 for the quarter ended June 30, 2018, compared to $124,000 for the same period in 2017.

The provision for loan losses increased $99,000, or 49.3%, to $300,000 for the three months ended June 30, 2018 from $201,000 for the same period in 2017 due to general increases in the Corporation's loan portfolio and higher than normal loan charge-offs experienced in the second quarter of 2018.

Noninterest expense increased $568,000, or 12.1%, to $5.2 million for the three months ended June 30, 2018 from $4.7 million for the same period in 2017.  The increase primarily related to increases in acquisition costs, compensation and benefits expense and federal deposit insurance of $252,000, $174,000 and $49,000, respectively.  Acquisition costs incurred during the second quarter of 2018 related to the pending acquisition of Community First Bancorp, Inc. totaled $358,000, compared to acquisition costs of $106,000 incurred during the second quarter of 2017 related to the acquisition of NHBT.  The increase in compensation and benefits expense related to costs associated with the operation of the new full-service banking office in Chester, West Virginia which was acquired from NHBT, increased health insurance costs and  normal salary and benefit increases.

The provision for income taxes decreased $32,000, or 10.2%, to $282,000 for the three months ended June 30, 2018 from $314,000 million for the same period in 2017 as a result of the enactment of the Tax Cuts and Jobs Act of 2017 and the decrease in the corporate tax rate to 21%.

CONSOLIDATED YEAR-TO-DATE OPERATING RESULTS OVERVIEW

Net income increased $778,000, or 38.9%, to $2.8 million or $1.21 per diluted share for the six months ended June 30, 2018, compared to $2.0 million or $0.92 per diluted share for the same period in 2017.  The increase resulted from increases in net interest income and noninterest income of $1.5 million and $224,000, respectively, and a decrease in provision for income taxes of $38,000, partially offset by increases in noninterest expense and the provision for loan losses of $683,000 and $317,000, respectively.

Net interest income increased $1.5 million, or 14.4%, to $12.0 million for the six months ended June 30, 2018, compared to $10.5 million for the same period in 2017.  The increase in net interest income resulted from an increase in interest income of $1.8 million, or 14.5%, as the Corporation experienced a $47.8 million increase in the average balance of loans.  Partially offsetting the increase in interest income, interest expense increased $308,000, or 14.8%, as the Corporation's average balance of interest-bearing deposits increased $67.8 million, partially offset by a $20.4 million decrease in the average balance of borrowed funds. The increases in the Corporation's loans and interest-bearing deposit balances resulted from strong production across the Bank's franchise and the aforementioned third quarter 2017 acquisition of NHBT.

The provision for loan losses increased $317,000, or 87.3%, to $680,000 for the six months ended June 30, 2018 from $363,000 for the same period in 2017 due to general increases in the Corporation's loan portfolio and higher than normal loan charge-offs experienced in the first half of 2018.

Noninterest income increased $224,000, or 13.0%, to $1.9 million for the six months ended June 30, 2018 from $1.7 million for the same period in 2017.  During the six months ended June 30, 2017, the Corporation recorded a $508,000 other-than-temporary impairment charge on a subordinated debt investment issued by First NBC Bank Holding Company.  Partially offsetting the impairment charge, the Corporation realized security gains of $350,000 during the six months ended June 30, 2017. During the six months ended June 30, 2018, the Corporation realized security losses of $30,000. Additionally, fees and service charges increased $58,000 as overdraft charges for the six months ended June 30, 2018 outpaced the same period in the prior year and other income increased $140,000 due to increased interchange fee income and fair value adjustments related to the Corporation's equity securities. Partially offsetting these favorable items, gains on the sales of loans totaled $24,000 for the six months ended June 30, 2018, compared to $130,000 for the same period in 2017.

Noninterest expense increased $683,000, or 7.4%, to $10.0 million for the six months ended June 30, 2018 from $9.3 million for the same period in 2017.  The increase primarily related to increases in compensation and benefits expense, acquisition costs, federal deposit insurance and professional fees of $304,000, $251,000, $78,000 and $53,000, respectively.  The increase in compensation and benefits expense related to costs associated with the operation of the new full-service banking office in Chester, West Virginia which was acquired from NHBT, increased health insurance costs and normal salary and benefit increases. Acquisition costs incurred during the first half of 2018 related to the pending acquisition of Community First Bancorp, Inc. totaled $358,000, compared to acquisition costs of $107,000 incurred during the first half of 2017 related to the acquisition of NHBT.

The provision for income taxes decreased $38,000, or 6.5%, to $548,000 for the six months ended June 30, 2018 from $586,000 million for the same period in 2017 as a result of the enactment of the Tax Cuts and Jobs Act of 2017 and the decrease in the corporate tax rate to 21%.

CONSOLIDATED BALANCE SHEET & ASSET QUALITY OVERVIEW

Total assets increased $25.2 million to $775.3 million at June 30, 2018 from $750.1 million at December 31, 2017.  Asset growth was driven by increases in cash and equivalents and net loans receivable of $16.2 million and $9.5 million, respectively.  Liabilities increased $24.8 million to $715.8 million at June 30, 2018 from $691.0 million at December 31, 2017 due to an increase in customer deposits of $30.9 million, partially offset by a $6.0 million reduction in borrowed funds.

Total nonperforming assets decreased to $3.3 million, or 0.43% of total assets at June 30, 2018, compared to $4.2 million, or 0.56% of total assets at December 31, 2017.

Stockholders’ equity increased $402,000 to $59.5 million at June 30, 2018 from $59.1 million at December 31, 2017 primarily due to a $1.6 million increase in retained earnings as a result of $2.8 million of net income, partially offset by $1.3 million of common dividends paid, and a $1.4 million decrease in accumulated other comprehensive income.  The Corporation remains well capitalized and is positioned for continued growth with total stockholders’ equity at 7.7% of total assets.  Tangible book value per common share was $21.51 at June 30, 2018, compared to $21.28 at December 31, 2017.

Emclaire Financial Corp is the parent company of The Farmers National Bank of Emlenton, an independent, nationally chartered, FDIC-insured community bank headquartered in Emlenton, Pennsylvania, operating 17 full service banking offices in Venango, Allegheny, Butler, Clarion, Clearfield, Crawford, Elk, Jefferson and Mercer counties, Pennsylvania and Hancock County, West Virginia.  The Corporation’s common stock is quoted on and traded through the NASDAQ Capital Market under the symbol “EMCF”.  For more information, visit the Corporation’s website at “www.emclairefinancial.com”.

This news release may contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements may contain words such as “believe”, “expect”, “anticipate”, “estimate”, “should”, “may”, “can”, “will”, “outlook”, “project”, “appears” or similar expressions.  Such forward-looking statements are subject to risk and uncertainties which could cause actual results to differ materially from those currently anticipated due to a number of factors. Such factors include, but are not limited to, changes in interest rates which could affect net interest margins and net interest income, the possibility that increased demand or prices for the Corporation's financial services and products may not occur, changing economic and competitive conditions, technological and regulatory developments, and other risks and uncertainties, including those detailed in the Corporation's filings with the Securities and Exchange Commission.  The Corporation does not undertake, and specifically disclaims any obligation to update any forward-looking statements to reflect occurrences or unanticipated events or circumstances after the date of such statements.

INVESTOR RELATIONS CONTACT:

William C. Marsh
Chairman, President and
Chief Executive Officer
Phone: (844) 800-2193
Email:  investor.relations@farmersnb.com

 
EMCLAIRE FINANCIAL CORP
Consolidated Financial Highlights
(Unaudited - Dollar amounts in thousands, except share data)
     
CONSOLIDATED OPERATING RESULTS DATA: Three month period   Six month period
      ended June 30,   ended June 30,
      2018   2017   2018   2017
Interest income $ 7,434     $ 6,432     $ 14,429     $ 12,605  
Interest expense   1,243       1,067       2,392       2,084  
  Net interest income     6,191       5,365       12,037       10,521  
Provision for loan losses   300       201       680       363  
Noninterest income   1,049       868       1,947       1,723  
Noninterest expense   5,245       4,677       9,981       9,298  
  Income before provision for income taxes     1,695       1,355       3,323       2,583  
Provision for income taxes   282       314       548       586  
  Net income   $ 1,413     $ 1,041     $ 2,775     $ 1,997  
                                   
Basic earnings per common share $ 0.62     $ 0.48     $ 1.22     $ 0.93  
Diluted earnings per common share $ 0.62     $ 0.48     $ 1.21     $ 0.92  
Dividends per common share $ 0.28     $ 0.27     $ 0.56     $ 0.54  
Return on average assets (1)   0.74 %     0.58 %     0.74 %     0.57 %
Return on average equity (1)   9.58 %     7.50 %     9.48 %     7.31 %
Yield on average interest-earning assets   4.18 %     3.94 %     4.13 %     3.94 %
Cost of average interest-bearing liabilities   0.88 %     0.82 %     0.86 %     0.81 %
Cost of funds   0.72 %     0.66 %     0.70 %     0.65 %
Net interest margin   3.48 %     3.30 %     3.45 %     3.30 %
Efficiency ratio   71.06 %     76.75 %     69.72 %     72.45 %
____________________              
(1) Returns are annualized for the three and six month periods ended June 30, 2018 and 2017.
         
CONSOLIDATED BALANCE SHEET DATA:   As of   As of
              6/30/2018   12/31/2017
Total assets         $ 775,319     $ 750,084  
Cash and equivalents           30,576       14,374  
Securities           100,360       101,167  
Loans, net           587,258       577,738  
Deposits           685,551       654,643  
Borrowed funds           20,050       26,000  
Stockholders' equity           59,493       59,091  
Book value per common share         $ 26.20     $ 26.02  
Tangible book value per common share         $ 21.51     $ 21.28  
Net loans to deposits           85.66 %     88.18 %
Allowance for loan losses to total loans           1.03 %     1.05 %
Nonperforming assets to total assets           0.43 %     0.56 %
Stockholders' equity to total assets           7.67 %     7.88 %
Shares of common stock outstanding           2,271,139       2,271,139  
                       
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 466

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 0

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 0

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 277

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 284

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 42

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading

Top 5 Most Recently Viewed Articles

Lawsuit Filed Alleging Eye Injury from Ozempic Use

Updated Category News Views 165

Parker Waichman LLP Takes Action Against Drug Manufacturer Parker Waichman, a prominent national law firm, is actively filing lawsuits for individuals who assert that they developed NAION after using Novo Nordisk's medications, Ozempic or Wegovy. The firm recently initiated a case for a Florida resident who experienced this severe eye condition after using Ozempic....

Continue Reading
C.H. Robinson Prepares for Upcoming Earnings Conference Call

Updated Category News Views 151

C.H. Robinson's Upcoming Earnings Release and Conference Call C.H. Robinson Worldwide, Inc. (Nasdaq: CHRW), a leading logistics provider, has announced significant plans for its upcoming earnings release. The company is scheduled to share its third quarter 2024 results post market close. On this important day, the company will hold a conference call to delve into the...

Continue Reading
PayPal Surges 14% After Exciting Partnership with OpenAI

Updated Category News Views 173

PayPal's Innovative Partnership with OpenAI Shares of PayPal Holdings Inc (NASDAQ: PYPL) experienced a notable increase of 14.38% in pre-market trading. This rise was sparked by the recent announcement of a deal between the payments giant and OpenAI. This partnership focuses on integrating PayPal's digital wallet into the popular AI platform, ChatGPT. Enabling...

Continue Reading
Unlocking the Future of Ridesharing: Uber and Nvidia's Game Changer

Updated Category News Views 199

Introduction to the Partnership In an exciting development, Uber Technologies Inc (NYSE: UBER) has announced a strategic partnership with Nvidia Corp (NASDAQ: NVDA) aimed at leveraging artificial intelligence (AI) to enhance ridesharing and autonomous vehicle technology. Analyst Justin Post from BofA Securities has enthusiastically maintained a Buy rating on Uber’s...

Continue Reading
Exploring the Future of Organic Infant Formula Market Growth

Updated Category News Views 275

Overview of Organic Infant Formula Market Growth The Organic Infant Formula market has seen remarkable expansion, indicating a shift in parental preferences towards health-conscious choices for their young ones. The market, which had a valuation of USD 20.8 billion in the recent past, is expected to reach an impressive USD 36.04 billion by 2032. This growth trajectory...

Continue Reading